Krito Pharma SRL
1.6 FTEKrito Pharma reported total assets of €2.01m at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Oct 2025), with 1.6 full-time equivalent.
The score of Krito Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets -8 % Headcount (avg FTE) -11 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Krito Pharma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 09 Oct 2025
- Year ended 31 Mar 2024filed on 15 Oct 2024
- Year ended 31 Mar 2023filed on 19 Oct 2023
- Year ended 31 Mar 2022filed on 28 Oct 2022
- Year ended 31 Mar 2021filed on 08 Oct 2021
Krito Pharma's financial analysis
- Solvency17.8%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Krito Pharma
Krito Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0500.718.255
- VAT number
- BE0500718255
- Peppol
- Registered · 0208:0500718255 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Nov 2012
- Registered office
- 3080 Tervuren
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 09 Oct 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Krito Pharma (SRL) has been based in Tervuren since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 79,606 € and equity of 359,179 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 17.8%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Krito Pharma
Companies in the same business, of comparable size and area, outside its group.
- Wuiame Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet €1.97m
- Hustings JO Management Retail sale of pharmaceutical products Wellen · balance sheet €2.13m
- Holding La Pharma Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.15m
- Libra Pharma Retail sale of pharmaceutical products Boechout · balance sheet €3.57m
- Vanheusden Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet €3.62m
- Apotes Retail sale of pharmaceutical products Herk-de-Stad · balance sheet €4.46m
- Pharmacie Herbint Retail sale of pharmaceutical products Evere · balance sheet €1.83m
- Pharmarive Retail sale of pharmaceutical products Etterbeek · balance sheet €1.80m
Frequently asked questions about Krito Pharma
What is the revenue of Krito Pharma?
Krito Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Krito Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0500718255 for Krito Pharma, if the company is VAT-registered. Its company number (CBE) is 0500.718.255.
Where is the registered office of Krito Pharma?
According to the CBE register, the registered office of Krito Pharma is in 3080 Tervuren.
What is the equity of Krito Pharma?
At the close of the 2025 financial year, the equity of Krito Pharma amounts to 359,179 €, a solvency of 17.8% of total assets.
How many people work at Krito Pharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Krito Pharma?
The register lists 4 active mandates at Krito Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Krito Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →